These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27777237)

  • 41. [Acute Psychosis after Consumption of Synthetic Cannabinoids].
    Mörkl S; Blesl C; Wurm WE; Tmava A
    Fortschr Neurol Psychiatr; 2016 Mar; 84(3):150-4. PubMed ID: 27029042
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthetic cannabis.
    Westin AA; Brede WR; Espnes KA
    Tidsskr Nor Laegeforen; 2012 Oct; 132(20):2289. PubMed ID: 23736197
    [No Abstract]   [Full Text] [Related]  

  • 43. A review on the abuse of three NPS (synthetic cannabinoids, kratom, poppers) among youths in Asia.
    Bae K; Kwon NJ; Han E
    Forensic Sci Int; 2018 Nov; 292():45-49. PubMed ID: 30273913
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cannabinoids related mental disorders].
    Konuma K; Nakamoto S
    Ryoikibetsu Shokogun Shirizu; 2003; (40):484-7. PubMed ID: 14626166
    [No Abstract]   [Full Text] [Related]  

  • 45. [Schizophrenia and cannabis consumption: epidemiology and clinical symptoms].
    Jockers-Scherübl MC
    Prax Kinderpsychol Kinderpsychiatr; 2006; 55(7):533-43. PubMed ID: 17058779
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthetic Cannabis and Myocardial Infarction: A Complication Less Known!
    Hirapara K; Aggarwal R
    Psychosomatics; 2015; 56(6):712-3. PubMed ID: 26674489
    [No Abstract]   [Full Text] [Related]  

  • 47. The Changing Drug Culture: Emerging Drugs of Abuse and Legal Highs.
    Albertson TE; Chenoweth JA; Colby DK; Sutter ME
    FP Essent; 2016 Feb; 441():18-24. PubMed ID: 26881769
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tubulointerstitial Injury and Drugs of Abuse.
    Nanavati A; Herlitz LC
    Adv Chronic Kidney Dis; 2017 Mar; 24(2):80-85. PubMed ID: 28284383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. What a downer: The dark side of cannabis.
    Rose DZ
    J Neurol Sci; 2016 May; 364():189-90. PubMed ID: 27004765
    [No Abstract]   [Full Text] [Related]  

  • 50. Synthetic Cannabinoids-Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis.
    Fattore L
    Biol Psychiatry; 2016 Apr; 79(7):539-48. PubMed ID: 26970364
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical characteristics of ER patients reporting synthetic cannabinoid use.
    Huecker M; Warf C; Ems T; Buckner K; Webb AN; Persaud A; Furmanek S; Shoff HW
    Am J Emerg Med; 2019 Jul; 37(7):1362-1363. PubMed ID: 30551937
    [No Abstract]   [Full Text] [Related]  

  • 52. Illicit Drugs and their Impact on Cardiovascular Pathology.
    Bădilă E; Hostiuc M; Weiss E; Bartoş D
    Rom J Intern Med; 2015; 53(3):218-25. PubMed ID: 26710497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A case of ischemic stroke after bonzai: syntetic cannabinoid from Turkey.
    Degirmenci Y; Kececi H; Olmez N
    Neurol Sci; 2016 Feb; 37(2):299-300. PubMed ID: 26466589
    [No Abstract]   [Full Text] [Related]  

  • 54. Assessing the Dangers of "Dabbing": Mere Marijuana or Harmful New Trend?
    Stogner JM; Miller BL
    Pediatrics; 2015 Jul; 136(1):1-3. PubMed ID: 26077476
    [No Abstract]   [Full Text] [Related]  

  • 55. A public health approach to increased synthetic cannabinoid-related morbidity among New York City residents, 2014-2015.
    Nolan ML; Allen B; Kunins HV; Paone D
    Int J Drug Policy; 2016 Aug; 34():101-3. PubMed ID: 27453146
    [No Abstract]   [Full Text] [Related]  

  • 56. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
    Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
    Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cannabinoid hyperemesis.
    Sannarangappa V; Tan C
    Intern Med J; 2009 Nov; 39(11):777-8. PubMed ID: 19912406
    [No Abstract]   [Full Text] [Related]  

  • 58. Personalised service.
    Prescrire Int; 2011 Jan; 20(112):4. PubMed ID: 21462781
    [No Abstract]   [Full Text] [Related]  

  • 59. Cannabis use and psychiatric and cogitive disorders: the chicken or the egg?
    Di Forti M; Morrison PD; Butt A; Murray RM
    Curr Opin Psychiatry; 2007 May; 20(3):228-34. PubMed ID: 17415074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Use and abuse of illicit drugs, also in the light of the new Italian legislation].
    D'Ettore A
    G Ital Med Lav Ergon; 2006; 28(1):112-4. PubMed ID: 16705899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.